These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30277153)

  • 1. Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review.
    Passero LFD; Cruz LA; Santos-Gomes G; Rodrigues E; Laurenti MD; Lago JHG
    Curr Top Med Chem; 2018; 18(15):1275-1286. PubMed ID: 30277153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
    Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
    Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings.
    Santana W; de Oliveira SSC; Ramos MH; Santos ALS; Dolabella SS; Souto EB; Severino P; Jain S
    Chem Biodivers; 2021 Sep; 18(9):e2100336. PubMed ID: 34369662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.
    Croft SL; Coombs GH
    Trends Parasitol; 2003 Nov; 19(11):502-8. PubMed ID: 14580961
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance in leishmaniasis.
    Croft SL; Sundar S; Fairlamb AH
    Clin Microbiol Rev; 2006 Jan; 19(1):111-26. PubMed ID: 16418526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches to discover marine antileishmanial natural products.
    Tempone AG; Martins de Oliveira C; Berlinck RG
    Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations.
    Bustamante C; Ochoa R; Asela C; Muskus C
    J Comput Aided Mol Des; 2019 Sep; 33(9):845-854. PubMed ID: 31612362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of Fenticonazole, Tioconazole and Nystatin on New World Leishmania Species.
    Yamamoto ES; Jesus JA; Bezerra-Souza A; Laurenti MD; Ribeiro SP; Passero LFD
    Curr Top Med Chem; 2018; 18(27):2338-2346. PubMed ID: 30569856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
    Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
    ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N, N', N″-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity.
    do Espírito Santo RD; Velásquez ÁMA; Passianoto LVG; Sepulveda AAL; da Costa Clementino L; Assis RP; Baviera AM; Kalaba P; Dos Santos FN; Éberlin MN; da Silva GVJ; Zehl M; Lubec G; Graminha MAS; González ERP
    Eur J Med Chem; 2019 Jun; 171():116-128. PubMed ID: 30913526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Synthetic Approaches for Bisnaphthalimidopropyl (BNIP) Derivatives as Potential Anti-Parasitic Agents for the Treatment of Leishmaniasis.
    Keskin E; Ucisik MH; Sucu BO; Guzel M
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31888250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear DNA replication and repair in parasites of the genus Leishmania: Exploiting differences to develop innovative therapeutic approaches.
    Uzcanga G; Lara E; Gutiérrez F; Beaty D; Beske T; Teran R; Navarro JC; Pasero P; Benítez W; Poveda A
    Crit Rev Microbiol; 2017 Mar; 43(2):156-177. PubMed ID: 27960617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on small molecule strategies targeting leishmaniasis.
    Kapil S; Singh PK; Silakari O
    Eur J Med Chem; 2018 Sep; 157():339-367. PubMed ID: 30099256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis?
    Ennes-Vidal V; Menna-Barreto RF; Branquinha MH; Dos Santos AL; D'Avila-Levy CM
    Parasitology; 2017 Feb; 144(2):117-123. PubMed ID: 27869056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of leishmaniasis: a review and assessment of recent research.
    Elmahallawy EK; Agil A
    Curr Pharm Des; 2015; 21(17):2259-75. PubMed ID: 25543123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational approaches for drug designing against leishmaniasis.
    Shukla AK; Singh BK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modes of action of Leishmanicidal antimicrobial peptides.
    Marr AK; McGwire BS; McMaster WR
    Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides for leishmaniasis.
    Cobb SL; Denny PW
    Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fitness of antimony-resistant Leishmania parasites: lessons from the field.
    Ait-Oudhia K; Gazanion E; Oury B; Vergnes B; Sereno D
    Trends Parasitol; 2011 Apr; 27(4):141-2. PubMed ID: 21216196
    [No Abstract]   [Full Text] [Related]  

  • 20. A "Golden Age" for the discovery of new antileishmanial agents: Current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione system.
    Rosa LB; Aires RL; Oliveira LS; Fontes JV; Miguel DC; Abbehausen C
    ChemMedChem; 2021 Jun; 16(11):1681-1695. PubMed ID: 33615725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.